Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
Conditions: Gram-negative Bacteremia; Bloodstream Infection Interventions: Diagnostic Test: Reveal Sponsors: Duke University; National Institute of Allergy and Infectious Diseases (NIAID); Parexel; BioM érieux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI)
DiscussionWe hypothesize that pulse-dose methylprednisolone administrated in the pre-hospital setting decreases inflammation and thus reduces final infarct size in patients with STEMI treated with primary PCI.Trial registrationEU-CT number: 2022 –500762-10–00; Submitted May 5, 2022. ClinicalTrials.gov Identifier: NCT05462730; Submitted July 7, 2022, first posted July 18, 2022. (Source: Trials)
Source: Trials - December 15, 2023 Category: Research Source Type: clinical trials
NIH Research Identifies Opportunities to Improve Future HIV Vaccine Candidates
December 14, 2023 -- An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from acquiring HIV, according to a new study from researchers at the National Institute of Allergy and... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 14, 2023 Category: Pharmaceuticals Source Type: clinical trials
Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
Conditions: Nervous System Disease; Immune System Disease Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Allergy Diagnostic Test Based on Microchip Technology
Conditions: Allergy; Allergy;Food; Allergy Pollen; Allergy Drug Interventions: Diagnostic Test: Routine allergy tests; Diagnostic Test: Newly developed microarray-based diagnostic test system Sponsors: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED
Conditions: COVID-19 Interventions: Behavioral: Vaccine Messaging; Behavioral: Vaccine Acceptance Question Sponsors: University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID); Pfizer; Duke University; Baylor College of Medicine; Thomas Jefferson University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
Investigation of Immune Amnesia Following Measles Infection in Select African Regions
Conditions: Measles Infection Interventions: Biological: Verorab Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Testing a Barbershop-based HIV Prevention Initiative Among Men
Conditions: HIV Infections Interventions: Behavioral: General, status-neutral HIV education; Diagnostic Test: HIV self-test kits; Other: Information about where to receive HIV prevention services; Behavioral: Barber-led peer support group education; Behavioral: Facility-based HIV risk reduction counseling; Diagnostic Test: Facility-based HIV testing; Other: Information about facility distributed HIV self-test kits; Diagnostic Test: STI testing Sponsors: HIV Prevention Trials Network; Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); National Instit...
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Safety Study of SLV213 for the Treatment of COVID-19.
Conditions: COVID-19 Interventions: Other: Placebo for SLV213; Drug: SLV213 Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Group CBT in Parents of Children With Food Allergy
Conditions: Parents Interventions: Behavioral: CBT Sponsors: University of Missouri, Kansas City Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Protocol CAUSE-03 / CHEETAH
Conditions: Asthma Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts
Conditions: Mpox Sponsors: Institute of Tropical Medicine, Belgium; Institut National de Recherche Biom édicale. Kinshasa, République Démocratique du Congo; National Institute of Allergy and Infectious Diseases (NIAID); Leidos Biomedical Research, Inc.; Alliance for International Medical Action; University of California, Los Angeles; Institut de Recherche pour le Developpement; University of Manito ba Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Hypoallergenicity of a New Formula in Subjects With Cow's Milk Allergy
Conditions: Allergy; Cow ' s Milk Allergy Interventions: Dietary Supplement: Liquid Extensively hydrolyzed cow ' s milk protein infant formula Sponsors: Federico II University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Analysis of Cellular Kinases and Aging in PBMCs and Colorectal Tissue
Conditions: HIV Infections; Aging Interventions: Other: biopsy Sponsors: Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Aging (NIA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas
Conditions: Granuloma; Aluminum Allergy Interventions: Diagnostic Test: Aluminum; Diagnostic Test: Tetanus toxoid Sponsors: National Allergy Research Center, Denmark Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
